T2 Biosystems, Inc. Proceeds from Stock Options Exercised
T2 Biosystems, Inc. reported Proceeds from Stock Options Exercised of $53.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-05-13
- T2 Biosystems, Inc. proceeds from stock options exercised for the quarter ending 2021-03-31 was $53.00K.
- T2 Biosystems, Inc. proceeds from stock options exercised for fiscal 2016 was $1.02M, a 43.57% decline from fiscal 2015.
- T2 Biosystems, Inc. proceeds from stock options exercised for fiscal 2015 was $1.80M, a 1079.08% increase from fiscal 2014.
- T2 Biosystems, Inc. proceeds from stock options exercised for fiscal 2014 was $153.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|
| 2021-03-31 | $53.00K 10-Q · filed 2021-05-13 | |
| 2016-12-31 | $1.02M 10-K · filed 2017-03-15 | |
| 2015-12-31 | $1.80M 10-K · filed 2017-03-15 | |
| 2014-12-31 | $153.00K 10-K · filed 2017-03-15 |